Smith & Nephew PLC
Veridion Score
Composite trend over time
Why is SNN moving today?
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for SNN.
SNN insider activity
Smith & Nephew PLC
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for SNN.
SNN contract awards, year to date.
Public federal awards linked to this ticker.
SNN lobbying filings, year to date.
Registered lobbying filings matched to Smith & Nephew PLC.